메뉴 건너뛰기




Volumn 33, Issue 6, 2014, Pages 664-666

Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis

Author keywords

adverse effects; drug resistance; drug therapy; Latent tuberculosis

Indexed keywords

AMINOTRANSFERASE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

EID: 84901479823     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000260     Document Type: Article
Times cited : (34)

References (13)
  • 1
    • 84856607254 scopus 로고    scopus 로고
    • Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis 2007-2010
    • Zignol M van Gemert W Falzon D et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis 2007-2010. Bull World Health Organ. 2012;90:111-119D.
    • (2012) Bull World Health Organ , vol.90
    • Zignol, M.1    Van Gemert, W.2    Falzon, D.3
  • 2
    • 0029910831 scopus 로고    scopus 로고
    • How contagious is tuberculosis
    • Sepkowitz KA. How contagious is tuberculosis Clin Infect Dis. 1996;23:954-962.
    • (1996) Clin Infect Dis , vol.23 , pp. 954-962
    • Sepkowitz, K.A.1
  • 4
    • 78650252700 scopus 로고    scopus 로고
    • Management of multidrug-resistant tuberculosis in children: A survival guide for paediatricians
    • Schaaf HS Marais BJ. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians. Paediatr Respir Rev. 2011;12:31-38.
    • (2011) Paediatr Respir Rev , vol.12 , pp. 31-38
    • Schaaf, H.S.1    Marais, B.J.2
  • 5
    • 0036256098 scopus 로고    scopus 로고
    • Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: A 30-month follow-up
    • DOI 10.1542/peds.109.5.765
    • Schaaf HS Gie RP Kennedy M et al. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics. 2002;109:765-771. (Pubitemid 34493340)
    • (2002) Pediatrics , vol.109 , Issue.5 , pp. 765-771
    • Simon Schaaf, H.1    Gie, R.P.2    Kennedy, M.3    Beyers, N.4    Hesseling, P.B.5    Donald, P.R.6
  • 6
    • 0034091974 scopus 로고    scopus 로고
    • Targeted tuberculin testing and treatment of latent tuberculosis infection
    • American Thoracic Society. Centers for Disease Control and Prevention and Infectious Disease Society of America
    • American Thoracic Society. Centers for Disease Control and Prevention and Infectious Disease Society of America. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221-S247.
    • (2000) Am J Respir Crit Care Med , vol.161
  • 8
    • 54049103333 scopus 로고    scopus 로고
    • Management of pediatric multidrugresistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003
    • Feja K McNelley E Tran CS et al.. Management of pediatric multidrugresistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003. Pediatr Infect Dis J. 2008:27:907-912.
    • Pediatr Infect Dis J , vol.2008 , Issue.27 , pp. 907-912
    • Feja, K.1    McNelley, E.2    Tran, C.S.3
  • 11
    • 0037441632 scopus 로고    scopus 로고
    • Treatment of tuberculosis
    • American Thoracic Society. Centers for Disease Control and Prevention and Infectious Disease Society of America
    • American Thoracic Society. Centers for Disease Control and Prevention and Infectious Disease Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603-662.
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 603-662
  • 12
    • 80053477373 scopus 로고    scopus 로고
    • The use of systemic and topical fluoroquinolones
    • Committee on Infectious Diseases American Academy of Pediatrics
    • Bradley JS Jackson MA; Committee on Infectious Diseases; American Academy of Pediatrics. The use of systemic and topical fluoroquinolones. Pediatrics. 2011;128:e1034-e1045.
    • (2011) Pediatrics , vol.128
    • Bradley, J.S.1    Jackson, M.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.